Nuvation Bio (NUVB)

Search documents
Nuvation Bio (NUVB) - 2020 Q3 - Quarterly Report
2020-11-16 15:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-39351 Panacea Acquisition Corp. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporati ...
Nuvation Bio (NUVB) - 2020 Q2 - Quarterly Report
2020-08-14 20:09
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 (Exact name of registrant as specified in its charter) | Delaware | 85-0862255 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 357 Tehama St, Floor 3 | | San Francisco, CA 94103 (Address of Principal Ex ...